News and Articles

The US Food and Drug Administration has approved levodopa inhalation powder (Inbrija, Acorda Therapeutics) for intermittent treatment of “off” episodes in... Read more »

In a growing trend toward inclusion, young adults with disabilities now have more opportunities than ever to live with typically-developing peers... Read more »

If you haven’t heard, 3-D printers have quickly become one of the hottest technologies on the market. These printers can be... Read more »

People with Parkinson’s disease who received zonisamide, in addition to levodopa and other anti-Parkinson’s medications had significantly reduced odds of developing... Read more »

Parkinson disease has a complicated relationship with psychiatric disorders. Some medications used to treat this disease can lead to psychosis or... Read more »

Researchers from the University of Edinburgh report that lovastatin (Mevacor, Altocor, etc.) corrected learning and memory problems in rats with a... Read more »

Decline in several cognitive domains continues for a decade after disease onset and is not attributable to medication effects.  Patients with... Read more »

The anticonvulsant ezogabine (also known as retigabine) significantly reduced depressive symptoms, anhedonia, and increased resilience to stress in a small open-label study... Read more »

Wide geographical disparities exist when it comes to opportunities for people with intellectual and developmental disabilities to live and work in... Read more »

A smartphone application that tracks a person’s heart rate may be able to detect diabetes using a photoplethysmography signal, which is... Read more »